Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Siltuximab> ?p ?o }
Showing triples 1 to 91 of
91
with 100 triples per page.
- Siltuximab abstract "Siltuximab (INN, trade name Sylvant; also known as CNTO 328, anti-IL-6 chimeric monoclonal antibody or cCLB8) is a chimeric (made from human and mouse proteins) monoclonal antibody. It binds to interleukin-6. Siltuximab has been investigated for the treatment of metastatic renal cell cancer, prostate cancer, and Castleman's disease, among other types of cancer.It has undergone a phase I clinical trial in patients With B-cell non-Hodgkin's lymphoma, multiple myeloma, or Castleman's disease. There were encouraging results in a small trial for advanced ovarian cancer.Encouraging results have been reported from a phase II trial for relapsed or refractory multiple myeloma.On April 23, 2014, siltuximab was FDA approved under the brand name of Sylvant for the treatment of patients with multicentric Castleman’s disease (MCD) who do not have human immunodeficiency virus (HIV) or human herpesvirus-8 (HHV-8).".
- Siltuximab atcPrefix "L04".
- Siltuximab atcSuffix "AC11".
- Siltuximab casNumber "541502-14-1".
- Siltuximab fdaUniiCode "T4H8FMA7IM".
- Siltuximab wikiPageID "21198093".
- Siltuximab wikiPageLength "9763".
- Siltuximab wikiPageOutDegree "42".
- Siltuximab wikiPageRevisionID "707386480".
- Siltuximab wikiPageWikiLink Abdominal_pain.
- Siltuximab wikiPageWikiLink Arthralgia.
- Siltuximab wikiPageWikiLink B_cell.
- Siltuximab wikiPageWikiLink Castlemans_disease.
- Siltuximab wikiPageWikiLink Category:Monoclonal_antibodies.
- Siltuximab wikiPageWikiLink Ciclosporin.
- Siltuximab wikiPageWikiLink Cytochrome_P450.
- Siltuximab wikiPageWikiLink Fusion_protein.
- Siltuximab wikiPageWikiLink HIV.
- Siltuximab wikiPageWikiLink Hyperuricemia.
- Siltuximab wikiPageWikiLink Interleukin_6.
- Siltuximab wikiPageWikiLink International_nonproprietary_name.
- Siltuximab wikiPageWikiLink Itch.
- Siltuximab wikiPageWikiLink Kaposis_sarcoma-associated_herpesvirus.
- Siltuximab wikiPageWikiLink Metastasis.
- Siltuximab wikiPageWikiLink Monoclonal_antibody.
- Siltuximab wikiPageWikiLink Mouse.
- Siltuximab wikiPageWikiLink Multiple_myeloma.
- Siltuximab wikiPageWikiLink Non-Hodgkin_lymphoma.
- Siltuximab wikiPageWikiLink Ovarian_cancer.
- Siltuximab wikiPageWikiLink Peripheral_edema.
- Siltuximab wikiPageWikiLink Plasma_cell.
- Siltuximab wikiPageWikiLink Prostate_cancer.
- Siltuximab wikiPageWikiLink Protein.
- Siltuximab wikiPageWikiLink Rash.
- Siltuximab wikiPageWikiLink Renal_cell_carcinoma.
- Siltuximab wikiPageWikiLink Theophylline.
- Siltuximab wikiPageWikiLink Upper_respiratory_tract_infection.
- Siltuximab wikiPageWikiLink Vascular_endothelial_growth_factor.
- Siltuximab wikiPageWikiLink Warfarin.
- Siltuximab wikiPageWikiLinkText "Siltuximab".
- Siltuximab wikiPageWikiLinkText "siltuximab".
- Siltuximab atcPrefix "L04".
- Siltuximab atcSuffix "AC11".
- Siltuximab c "6450".
- Siltuximab casNumber "541502".
- Siltuximab chemspiderid "none".
- Siltuximab h "9932".
- Siltuximab legalUs "Rx-only".
- Siltuximab mabType "mab".
- Siltuximab molecularWeight "145".
- Siltuximab n "1688".
- Siltuximab o "2016".
- Siltuximab pregnancyUs "C".
- Siltuximab s "50".
- Siltuximab source "xi/o".
- Siltuximab synonyms "CNTO 328".
- Siltuximab target Interleukin_6.
- Siltuximab tradename "Sylvant".
- Siltuximab type "mab".
- Siltuximab unii "T4H8FMA7IM".
- Siltuximab verifiedfields "changed".
- Siltuximab verifiedrevid "464390611".
- Siltuximab watchedfields "changed".
- Siltuximab wikiPageUsesTemplate Template:Cascite.
- Siltuximab wikiPageUsesTemplate Template:Chemspidercite.
- Siltuximab wikiPageUsesTemplate Template:Drugbankcite.
- Siltuximab wikiPageUsesTemplate Template:Drugbox.
- Siltuximab wikiPageUsesTemplate Template:Fdacite.
- Siltuximab wikiPageUsesTemplate Template:Monoclonals_for_tumors.
- Siltuximab wikiPageUsesTemplate Template:Reflist.
- Siltuximab subject Category:Monoclonal_antibodies.
- Siltuximab hypernym Antibody.
- Siltuximab type ChemicalSubstance.
- Siltuximab type Drug.
- Siltuximab type Antibody.
- Siltuximab type Chemical.
- Siltuximab type Drug.
- Siltuximab type Redirect.
- Siltuximab type ChemicalObject.
- Siltuximab type Thing.
- Siltuximab type Q8386.
- Siltuximab comment "Siltuximab (INN, trade name Sylvant; also known as CNTO 328, anti-IL-6 chimeric monoclonal antibody or cCLB8) is a chimeric (made from human and mouse proteins) monoclonal antibody. It binds to interleukin-6. Siltuximab has been investigated for the treatment of metastatic renal cell cancer, prostate cancer, and Castleman's disease, among other types of cancer.It has undergone a phase I clinical trial in patients With B-cell non-Hodgkin's lymphoma, multiple myeloma, or Castleman's disease.".
- Siltuximab label "Siltuximab".
- Siltuximab sameAs Q3960572.
- Siltuximab sameAs Siltuximab.
- Siltuximab sameAs Siltuximab.
- Siltuximab sameAs m.05c0nl7.
- Siltuximab sameAs Силтуксимаб.
- Siltuximab sameAs Q3960572.
- Siltuximab wasDerivedFrom Siltuximab?oldid=707386480.
- Siltuximab isPrimaryTopicOf Siltuximab.